- Insights into the industry from mature bulk commodities to the next generation of differentiated technologies

The subcutaneous injection needle is one of the most produced precision metal parts in human medical history - with an annual output of hundreds of billions of units. This makes it, on the one hand, extremely mature (with processes, standards, and supply chains "down to the bone"), and on the other hand, constantly pushed forward by new demands: thinner and more comfortable, safer from needle pricks, more intelligent drug delivery interfaces, and greener manufacturing. From the perspective of manufacturers, these five dimensions determine the direction of "making the needle" from a commodity to a value-added product.

I. "More Refined" Physical Ceiling - How Fine Can We Make the Needles?

The current most fine production grade is 33G-34G (OD ≈ 0.20-0.18mm, close to the thickness of a hair). It is typically used in insulin pens or very short intradermal injections. But going further down will encounter three obstacles:

1. Stiffness Wall: OD ↓ → Section moment of inertia ↓⁴ relationship → The tube becomes more prone to bending. You must use UTW / ultra-thin wall to support the lumen, but the wall thickness cannot be so thin as to cause elliptical collapse during puncture.
2. Flow Wall: Poiseuille's Law states that flow ∝ r⁴ - if the radius is halved, the flow drops to 1/16. The clinical approach is usually to shorten the effective length (4-6mm ultra-short needles) to maintain acceptable pressure, while compensating for the insufficient depth by relying on large-area subcutaneous capillary absorption.
3. Manufacturing Wall: The 34G needle tube is drawn, sharpened, transported, and automated visual inspection - every step's vibration and electrostatic adsorption needs to be redesigned because the parts have reached a size where they are almost "too small to be held by a finger".
4. Therefore, the next generation "more comfortable" does not necessarily mean "finer", but may mean: the same gauge has lower puncture force (better slope algorithm + more uniform silicone coating + smoother lumen) + ultra-short design reduces the depth of tissue penetration.

II. "Even Slimmer" Advancement - New Surface Engineering Beyond Silicone Oil

Although traditional PDMS silicone oil coating is mature, it faces two major doubts:

Extractable/micro-particle complaints (especially for highly sensitive liquid medications such as certain biological preparations)

Concerns about the interaction between silicone oil and protein-based drugs (silicone oil droplets may serve as anodic nucleation sites for protein aggregation)

The industry is exploring:

Ultra-clean electrolytic polishing + ultra-low roughness Ra to reduce friction and achieve a "dry smooth" path (reducing coating dependency)

Covalent bonding siloxane / plasma polymer film (more stable, less free oil)

Hydrophilic polymer brush coating (PEG-like) alters surface energy, enabling the spontaneous formation of a lubricating layer by water film

These technologies are still undergoing triple verification of cost, stability, and regulation, but the direction is clear: lubrication is moving from "applying a layer of oil" to "engineering the surface".

III. "Safer" - "Safety Engineered Device" for Preventing Needlestick Injuries Has Become a Mandatory Requirement Under Regulations

The WHO and most major regulatory regions have explicitly required that medical institutions prioritize the use of safety engineering needles (Sharps Injury Protection): the needle retracts/locks automatically after use to prevent healthcare workers from being injured by discarded needles.

For manufacturers, this means: The needle is no longer just "bare metal + Hub", but a miniature mechanical structure consisting of the needle, the mechanical protection mechanism, and the activation mechanism. This, in turn, leads to:

The Hub area requires higher precision for multi-piece assembly (springs/sliders/clips)

Assembly cleanliness and system reliability must both be up to standard

The cost structure has shifted from "a few cents" to "a few cents more" - but the clinical value (zeroing out of occupational exposure to HBV/HCV/HIV) is the fundamental principle.

IV. "Smarter" - Needles Are Becoming Miniature Sensing/Transmitting Interfaces

Frontier (still in the stage of clinical application) includes:

Microneedle patches are discussed alongside subcutaneous needles: the former is more suitable for vaccine/macro-molecule transdermal delivery, while the latter remains the main force for fluid infusion.

Integrated sensor needles: integrate miniature temperature sensors or conductivity probes on the needle tube wall to determine "am I in the vein or in the surrounding tissues" in real time - reducing the error rate of IV punctures (currently, most of the solutions are based on the catheter end, but the micro-implantation process of the needle wall is of the same lineage as it).

V. "More Green" - Self-Inspection of Supply Chain Under ESG Pressure

The carbon footprint of a single needle is small, but the cumulative total for hundreds of billions of needles is significant. What can be done at the manufacturing end:

Reduce EO dependence (switch to validated low-dose irradiation or alternative processes)

Decrease waste: Closed-loop recycling of drawn waste tubes, re-injection of Hub injection ports (under food-contact/medical-grade compliance conditions)

Packaging reduction: Convergence from large plastic blister packaging to more compact Tyvek design

Conclusion

The subcutaneous injection needle may seem like an "old technology" - but precisely because of this old technology, it best illustrates a principle: when production volumes reach tens of billions, risks are measured in terms of human bodies, and standards are measured in terms of ISO three-digit numbers, any "seemingly simple" improvement requires materials science, geometry, surface chemistry, mechanics, and quality systems to all advance one step forward simultaneously. For Manners Technology and its counterparts in the same level of precision manufacturing, the true moat is not a single piece of equipment, but the ability to write every step of this "from the stainless steel main pipe to the opening of the sterile bag" thousand-step chain in a process language that is reproducible, measurable, and traceable - and then, on this basis, gradually make the needle thinner, smoother, safer, and smarter. After all, humans may one day reduce the number of injections, but as long as injections are still needed, this half-second of metal should be made the best.

Note: The information regarding the framework, test items, size range (10G → 3.4mm to 34G → 0.18mm), wall thickness grades (RW/TW/ETW/UTW), etc. in the above article is based on the public summaries of ISO and authoritative interpretations in the industry. The specific product parameters (gauge/length/HUB configuration/sterilization method) should be in accordance with your actual products DHF/DMR and customer specifications. If you would like me to align the content of the five articles to the existing product item list of Manners (gauge range, Hub type, certification number, production line equipment list) and perform a second "brand customization refinement", please let me know your actual SKUs/process routes and I will refine each article accordingly.